TY - JOUR T1 - Rational application of the new European Society for Paediatric Gastroenterology, Hepatology and Nutrition (ESPGHAN) 2020 criteria for the diagnosis of coeliac disease JO - Anales de Pediatría (English Edition) T2 - AU - Riechmann,Enriqueta Román AU - Villasante,Gemma Castillejo de AU - Pascual,M. Luz Cilleruelo AU - Aliaga,Ester Donat AU - Allué,Isabel Polanco AU - Sánchez-Valverde,Félix AU - Koninckx,Carmen Ribes SN - 23412879 M3 - 10.1016/j.anpede.2019.12.001 DO - 10.1016/j.anpede.2019.12.001 UR - https://analesdepediatria.org/en-rational-application-new-european-society-articulo-S234128792030003X AB - Coeliac disease is a systemic immune-mediated disorder triggered by the ingestion of gluten, which is given in genetically predisposed subjects. It manifests with a wide variety of clinical symptoms, specific serological markers, HLA-DQ2/DQ8 haplotype, and enteropathy. The criteria followed for this have usually been those established by the European Society for Paediatric Gastroenterology, Hepatology and Nutrition (ESPGHAN) since 1969. These criteria have advanced from the need of several intestinal biopsies to, thanks to the development of serological tests of high sensitivity and specificity, considering the enteropathy as one more element in this diagnosis and makes it possible to perform a diagnosis without the need of an intestinal biopsy in certain circumstances. The updated review of the 2012 criteria in 2019 provides new evidence on some aspects, such as the role of HLA, the diagnosis of asymptomatic patients, and the effectiveness of the serological markers. These aspects are reviewed in detail, with the aim of facilitating the rational application of the new 2020 criteria at all care levels. In this sense, Paediatric Primary Care is fundamental in the search for active cases and to perform a first serological study, being recommended that the diagnosis is always established by a Paediatric Gastroenterologist. ER -